TrademarkDir
CHOOSE PREVENTION
LIVE

Serial Number

97372332

Owner

Ojai Retinal Technology, LLC

Attorney

Scott W. Kelley

First Use Date

Nov 5, 2023

Filing Date

Apr 20, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CHOOSE PREVENTION Trademark

Serial Number: 97372332 • Registration: 7836421

CHOOSE PREVENTION is a trademark filed by Ojai Retinal Technology, LLC on April 20, 2022. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Ojai Retinal Technology, LLC (45 trademarks)

#88
Los Angeles, CA 90024

Entity Type: 16

Trademark Details

Filing Date

April 20, 2022

Registration Date

June 17, 2025

First Use Anywhere

November 5, 2023

First Use in Commerce

November 5, 2023

Published for Opposition

March 21, 2023

Goods & Services

Medical services in the field of chronic and progressive diseases of the ocular posterior segment, namely, age-related, metabolic, inherited, inflammatory, congenital, idiopathic and other eye-related diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 17, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 17, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 28, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 28, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 15, 2025 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 10, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 10, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 12, 2024 GNFN
FINAL REFUSAL E-MAILED
Nov 12, 2024 GNFR
SU - FINAL REFUSAL - WRITTEN
Nov 12, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 19, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 29, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Aug 29, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2024 CRFA
ASSIGNED TO LIE
Jul 9, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 3, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 3, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jan 3, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Nov 28, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 28, 2023 AITU
USE AMENDMENT FILED
Nov 15, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 15, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 4, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 2, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 2, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 2, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 16, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 21, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 7, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 7, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 7, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 7, 2023 CNEA
ASSIGNED TO EXAMINER
Feb 7, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2022 NWOS
NEW APPLICATION ENTERED
Apr 23, 2022 NWAP

Related Trademarks

More from this Owner

THERMOCEUTICAL

THERMOCEUTICAL

LASERCEUTICAL

LASERCEUTICAL

THERMAL (THERMAL HORMESIS-ELICITED RETINOTHERAPY MAXIMIZED FOR ADAPTATIVE LONGEVITY)

THERMAL (THERMAL HORMESIS-ELICITED RETINOTHERAPY MAXIMIZED FOR ADAPTATIVE LONGEVITY)

OPTOCEUTICAL

OPTOCEUTICAL

PHOTONICEUTICAL

PHOTONICEUTICAL

OPTICEUTICAL

OPTICEUTICAL